Á¦8ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö : 2023-09-23
±³À°ÀÏÀÚ : 2023-09-23
±³À°Àå¼Ò : ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ °Àǵ¿ 1Ãþ Á×¼º°ÀǽÇ
±³À°ÁÖÁ¦ : Á¦8ȸ ¿µ³²±Û·Î¹ú ºñ´¢ÀÇÇÐ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¿µ³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºñ´¢ÀÇÇаú
´ã´çÀÚ : ±è¿µ¿í
¿¬¶ôó : 053-620-3170
À̸ÞÀÏ : jojo9174@hanmail.net
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 10:00~10:20 Oncology Session – Cutting-edge debate for Critical Clinical Scenarios 1. Kidney Cancer: Is Cytoreductive Neprectomy Dead or Alive in 2023? ±Ç¼¼À±(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 10:20~10:35 Oncology Session – Cutting-edge debate for Critical Clinical Scenarios 2. Bladder cancer: Is radical cystectomy still the preferred treatment for BCG-resistant NMIBC? ½ÅÅÃÁØ(°è¸íÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 10:35~10:50 Oncology Session – Cutting-edge debate for Critical Clinical Scenarios 3. Prostate cancer: What is the optimal treatment for super-elderly high-risk prostate cancer? °í¿µÈÖ(¿µ³²ÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 10:50~11:00 panel discussion ±èÀç¼ö(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 11:00~11:20 Endourology session – Hot topics in Urolithiasis 1. What¡¯s new in disposable flexible ureterosope ±è¿õºó(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 11:20~11:35 Endourology session – Hot topics in Urolithiasis 2. Asymptomatic renal stone: what shall we do? ±è¹ü¼ö(°æºÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 11:35~11:50 Endourology session – Hot topics in Urolithiasis 3. Managing symptoms after URS: practical tips ±èÅÂÇö(Â÷ÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 11:50~12:00 panel discussion ¿À°æÁø(Àü³²ÀÇ´ë)
½Ä»ç 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 12:00~13:30 ½Ä»ç ()
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 13:30~13:55 Voiding dysfunction session – The management & prevention of complications after LUTS&BPH surgery. 1. Mid-urethral sling procedure º¯ÇýÁø(°è¸íÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 13:55~14:20 Voiding dysfunction session – The management & prevention of complications after LUTS&BPH surgery. 2. HoLEP ±è¿µ¿í(¿µ³²ÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 14:20~14:30 panel discussion ±è°Ç³²(±¸¹ÌÂ÷ÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 14:30~14:55 Infection session – Antibiotics resistance in UTI 1. The current state & mechanism of antibiotics resistance in UTI ±è¿¬ÁÖ(´ë±¸ÆÄŸ¸¶º´¿ø)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 14:55~15:20 Infection session – Antibiotics resistance in UTI 2. Urologic perspective & future in antibiotics resistance Çã°æÀç(´ë±¸ÆÄƼ¸¶º´¿ø)
Åä·Ð 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 15:20~15:30 panel discussion ±Ç»óÅÃ(¸ÇÆÄ¿öºñ´¢±â°ú)
ÈÞ½Ä 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 15:30~16:00 Coffee break ()
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 16:00~16:25 Andrology session – Ejaculatory dysfunction & AI 1. Premature & delayed ejaculation ÇÏÀ±¼®(°æºÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 16:25~16:50 Andrology session – Ejaculatory dysfunction & AI 2. AI & Sex: where do we stand in 2023? ÀÌ¿ø±â(ÇѸ²ÀÇ´ë)
Åä·Ð 09¿ù 23ÀÏ ÀÇ°ú´ëÇÐ 1Ãþ Á×¼º°ÀÇ½Ç 16:50~17:00 panel discussion ¹ÚÇöÁØ(ºÎ»êÀÇ´ë)